Pharma Holdings Management
Christian Lütken, CEO
years of experience in the fields of pediatrics, family medicine, emergency medicine and occupational medicine. He has management experience as previous Head of Department in a private healthcare company. In recent years Christian has been working in DNB’s Global Healthcare team financing healthcare companies globally, and also working closely with the Norwegian healthcare startup scene comprising all subsegments of the healthcare industry including med.tech, pharma, bio tech, digital health and healthcare services.
Christian is located in Oslo, Norway
Torsteinn Erlingsson, CFO
Master Science degree in Fishery Science from UiT, the Arctic University of Norway. He has more than 25 years of experience from corporate finance and business development. In his tenure in corporate finance Erlingsson worked on several biotech transactions, and in Pharma Holdings Mr. Erlingsson has secured equity financing for the relaunch of the development of our lead drug candidate.
Torsteinn is located in Tromsø, Norway
Edvard Christian Fuglset Dahl, CBDO
Edvard is located in Oslo, Norway
Niklas Hammarstedt, CQO
He has more than 10 years of experience from working within the pharmaceutical and biotechnological industries specifically in roles within Quality Control, production management, project management and Quality Assurance.
The majority of his experience was gathered working at Octapharma AB starting in QC, then as Head of Production Documentation managing master batch records, batch record review and company SOPs, and finally working in QA. In his last position, as CQO at Atlas Antibodies AB, Niklas has been focusing on defining and building quality routines into a company-wide quality management system, from a compliance and sustainability perspective, combined with adapting best practices. Process compliance and efficiency together with supportive system implementation, integration and optimization were key needs and focus areas throughout previous positions.
Niklas is located in Stockholm, Sweden
Johnny Ryvoll, VP Projects
Johnny is located in Tromsø, Norway
Rolf Engstad, Contracted CMC Lead
Engstad was chief scientific officer (CSO) in Biotec Pharmacon for almost 20 years and in charge of the successful development of pharmaceutical and medical device products, as well as responsible for pre-clinical and clinical studies. He has longstanding research collaborations with international institutions like the Charité in Berlin, the Memorial Sloan Kettering Cancer Centre, and the Mount Sinai Hospital, both New York, as well as with many Norwegian universities and research institutes. Engstad is also the inventor of more than 20 granted patents and patent applications.